Gabriel
Well-Known Member
Back of the cigarette packet time,but J&J initiated the single-dose Phase 1&2 trial on July 22nd 2020 and have their Phase 3 results now, so six months. In the interim, they initiated their double-dose Phase 1&2 trial on November 15th, so presumably they’ll have an inkling of the results of that and its Phase 3 around May 15th, which ought to be about the time they actually start delivering stocks.
If the double-dose proves significantly more effective, then would it not be prudent to wait and see before deciding which protocol to follow?
If the double-dose proves significantly more effective, then would it not be prudent to wait and see before deciding which protocol to follow?